Publication:
Metabolic characterization of two different non-alcoholic fatty liver disease pre-clinical mouse models.

dc.contributor.authorGallego-Durán, Rocío
dc.contributor.authorÁlvarez-Amor, Leticia
dc.contributor.authorGil-Gómez, Antonio
dc.contributor.authorRojas, Ángela
dc.contributor.authorMuñoz-Hernández, Rocío
dc.contributor.authorCádernas-García, Antonio
dc.contributor.authorMaya-Miles, Douglas
dc.contributor.authorMontero-Vallejo, Rocío
dc.contributor.authorGato, Sheila
dc.contributor.authorSánchez Torrijos, Yolanda
dc.contributor.authorAmpuero, Javier
dc.contributor.authorMartín, Francisco
dc.contributor.authorRomero-Gómez, Manuel
dc.date.accessioned2023-01-25T13:32:16Z
dc.date.available2023-01-25T13:32:16Z
dc.date.issued2019
dc.description.abstractnon-alcoholic fatty liver disease is one of the most prevalent liver disorders in the developed world. Currently, there is no approved pharmacological therapy except for lifestyle intervention. Therefore, there is a need to increase the knowledge of preclinical models in order to boost novel discoveries that could lead to a better therapeutic management. this study characterized the effects of two different diets, a long-term high-fat high-fructose diet (HF-HFD) and a choline-deficient, methionine supplemented high-fat diet (CDA-HFD) in C57BL/6J mice for 52 weeks or 16 weeks, respectively. Body weight, lipid and hepatic profile were analyzed and liver histology was subsequently evaluated. HF-HFD animals had an increased body weight and total cholesterol levels, whereas the opposite occurred in CDA-HFD. Both HF-HFD and CDA-HFD animals had higher ALT and AST levels. With regard to histology findings, HF-HFD and CDA-HFD diets induced an increased collagen deposit and intrahepatic steatosis accumulation. in conclusion, the comparison of these models aided in the selection of a long-term, more physiological model for physiopathology studies or a more rapid NASH model for novel molecule testing.
dc.identifier.doi10.17235/reed.2019.6083/2018
dc.identifier.issn1130-0108
dc.identifier.pmid30896960
dc.identifier.unpaywallURLhttps://doi.org/10.17235/reed.2019.6083/2018
dc.identifier.urihttp://hdl.handle.net/10668/13743
dc.issue.number4
dc.journal.titleRevista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva
dc.journal.titleabbreviationRev Esp Enferm Dig
dc.language.isoen
dc.organizationCentro Andaluz de Biología Molecular y Medicina Regenerativa-CABIMER
dc.organizationInstituto de Biomedicina de Sevilla-IBIS
dc.organizationHospital Universitario Virgen del Rocío
dc.page.number301-307
dc.pubmedtypeJournal Article
dc.rights.accessRightsopen access
dc.subject.meshAlanine Transaminase
dc.subject.meshAnimals
dc.subject.meshAspartate Aminotransferases
dc.subject.meshBody Weight
dc.subject.meshCholesterol
dc.subject.meshCholine
dc.subject.meshDiet, High-Fat
dc.subject.meshDisease Models, Animal
dc.subject.meshFructose
dc.subject.meshLiver
dc.subject.meshMale
dc.subject.meshMethionine
dc.subject.meshMice
dc.subject.meshMice, Inbred C57BL
dc.subject.meshNon-alcoholic Fatty Liver Disease
dc.subject.meshRandom Allocation
dc.subject.meshSweetening Agents
dc.titleMetabolic characterization of two different non-alcoholic fatty liver disease pre-clinical mouse models.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number111
dspace.entity.typePublication

Files